Inozyme Pharma, Inc.
NASDAQ:INZY
5.15 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 1.976 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0.188 | 0.182 | 0.306 | 0.333 | 0.331 | 0.324 | 0.312 | 0.299 | 0.285 | 0.281 | 0.281 | 0.167 | 0.167 | 0.158 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| -0.188 | -0.182 | 1.67 | -0.333 | -0.331 | -0.324 | -0.312 | -0.299 | -0.285 | -0.281 | -0.281 | -0.167 | -0.167 | -0.158 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0 | 0.845 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 21.57 | 19.111 | 17.807 | 13.341 | 11.666 | 11.857 | 13.837 | 12.191 | 10.007 | 11.814 | 13.551 | 9.346 | 8.22 | 6.603 | 7.036 | 25.174 | 7.877 | 6.406 | 5.279 | 3.317 | 3.489 | 4.134 |
| Algemene en administratieve kosten
| 5.907 | 5.234 | 4.825 | 4.733 | 4.728 | 6.512 | 5.696 | 4.721 | 5.384 | 5.025 | 5.206 | 4.916 | 4.435 | 4.369 | 4.235 | 3.142 | 1.671 | 1.5 | 1.489 | 1.003 | 1.064 | 1.03 |
| Verkoop- en marketingkosten
| 0 | 0 | -0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 5.907 | 5.234 | 4.695 | 4.733 | 4.728 | 6.512 | 5.696 | 4.721 | 5.384 | 5.025 | 5.206 | 4.916 | 4.435 | 4.369 | 4.235 | 3.142 | 1.671 | 1.5 | 1.489 | 1.003 | 1.064 | 1.03 |
| Overige kosten
| -0.003 | -0.051 | 0.014 | 0.02 | -0.028 | -0.034 | 0.174 | -0.197 | -0.191 | -0.105 | -0.04 | -0.065 | 0.057 | -0.141 | 0.089 | 0.157 | 0.004 | -0.003 | 0.01 | -0.003 | -0.014 | -0.017 |
| Bedrijfskosten
| 27.477 | 24.345 | 22.502 | 18.074 | 16.394 | 18.369 | 19.533 | 16.912 | 15.391 | 16.839 | 18.757 | 14.262 | 12.655 | 10.972 | 11.271 | 28.316 | 9.548 | 7.906 | 6.768 | 4.32 | 4.553 | 5.164 |
| Bedrijfsresultaat
| -27.665 | -24.345 | -22.808 | -18.074 | -16.394 | -18.369 | -19.533 | -16.912 | -15.391 | -16.839 | -18.757 | -14.262 | -12.655 | -10.972 | -11.271 | -28.316 | -9.548 | -7.906 | -6.768 | -4.32 | -4.553 | -5.164 |
| Bedrijfsresultaat ratio
| 0 | 0 | -11.543 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 0.632 | 0.998 | 1.264 | 1.436 | -0.028 | 0.965 | 0.989 | 0.54 | 0.13 | -0.045 | -0.04 | -0.065 | 0.057 | -0.141 | 0.089 | 0.157 | 0.004 | -0.003 | 0.01 | -0.003 | -0.014 | -0.017 |
| Inkomen voor belasting
| -27.033 | -23.347 | -21.544 | -16.638 | -15.583 | -17.404 | -18.544 | -16.372 | -15.261 | -16.884 | -18.754 | -14.28 | -12.54 | -11.05 | -11.118 | -28.095 | -9.473 | -7.738 | -6.544 | -4.035 | -4.173 | -4.971 |
| Inkomen voor belasting ratio
| 0 | 0 | -10.903 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | -0.182 | 2.219 | -0.208 | -0.839 | -1.172 | -0.989 | -0.54 | -0.321 | 0.045 | -0.003 | -0.047 | -0.058 | -0.063 | -0.064 | -0.064 | -0.071 | -0.171 | -0.214 | -0.288 | -0.394 | -0.21 |
| Nettowinst
| -27.033 | -23.347 | -21.544 | -16.638 | -15.583 | -16.232 | -17.555 | -15.832 | -14.94 | -16.929 | -18.754 | -14.28 | -12.54 | -11.05 | -11.118 | -28.095 | -9.473 | -7.738 | -6.544 | -4.035 | -4.173 | -4.971 |
| Nettowinstmarge
| 0 | 0 | -10.903 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.44 | -0.38 | -0.35 | -0.29 | -0.35 | -0.37 | -0.43 | -0.36 | -0.38 | -0.71 | -0.79 | -0.6 | -0.53 | -0.47 | -0.61 | -1.55 | -0.47 | -0.51 | -0.43 | -0.27 | -0.28 | -0.33 |
| Verwaterde WPA
| -0.44 | -0.38 | -0.35 | -0.29 | -0.35 | -0.37 | -0.43 | -0.36 | -0.38 | -0.71 | -0.79 | -0.6 | -0.53 | -0.47 | -0.61 | -1.55 | -0.47 | -0.51 | -0.43 | -0.27 | -0.28 | -0.33 |
| EBITDA
| -27.477 | -24.345 | -22.502 | -18.074 | -16.185 | -18.369 | -19.335 | -16.723 | -15.212 | -16.661 | -18.575 | -14.095 | -12.488 | -10.814 | -11.148 | -28.273 | -9.522 | -7.881 | -6.743 | -4.3 | -4.534 | -5.145 |
| EBITDA ratio
| 0 | 0 | -11.388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |